Clinical Characteristics and Prognosis of Hospital-Acquired Klebsiella pneumoniae Bacteremic Pneumonia versus Escherichia coli Bacteremic Pneumonia: A Retrospective Comparative Study

References

• Lanks CW, Musani AI, Hsia DW. Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am. 2019;103(3):487–501. doi:10.1016/j.mcna.2018.12.008
   PubMed Web of Science ®Google Scholar
• Myrianthefs P, Ioannidis K, Baltopoulos G, et al. Treatment of hospital-acquired pneumonia. Lancet Infect Dis. 2011;11(10):729–730. doi:10.1016/S1473-3099(11)70263-8
   PubMedGoogle Scholar
• Rosenthal VD, Maki DG, Mehta Y, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007–2012. Device-associated module. Am J Infect Control. 2014;42(9):942–956. doi:10.1016/j.ajic.2014.05.029
   PubMed Web of Science ®Google Scholar
• Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care–associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732–1744. doi:10.1056/NEJMoa1801550
   PubMed Web of Science ®Google Scholar
• Bart SM, Rubin D, Kim P, et al. Trends in hospital-acquired and ventilator-associated bacterial pneumonia trials. Clin Infect Dis. 2021;73(3):e602–e8. doi:10.1093/cid/ciaa1712
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik A, Rizvi M, et al. Epidemiology of multidrug-resistant Gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients. J Glob Antimicrob Resist. 2017;9:47–50. doi:10.1016/j.jgar.2016.12.016
   PubMed Web of Science ®Google Scholar
• Wang M, Earley M, Chen L, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22(3):401–412. doi:10.1016/S1473-3099(21)00399-6
   PubMed Web of Science ®Google Scholar
• Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51 Suppl 1:S81–7. doi:10.1086/653053
   PubMed Web of Science ®Google Scholar
• Algammal A, Hetta HF, Mabrok M, et al. Editorial: emerging multidrug-resistant bacterial pathogens “superbugs”: a rising public health threat. Front Microbiol. 2023;14:1135614. doi:10.3389/fmicb.2023.1135614
   PubMed Web of Science ®Google Scholar
• Xu A, Zheng B, Xu YC, et al. National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clin Microbiol Infect. 2016;22(1):S1–8. doi:10.1016/j.cmi.2015.09.015
   PubMedGoogle Scholar
• Martin-Loeches I, Rodriguez AH, Torres A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe. Curr Opin Crit Care. 2018;24(5):347–352. doi:10.1097/MCC.0000000000000535
   PubMed Web of Science ®Google Scholar
• Karampatakis T, Tsergouli K, Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics. 2023;12(2). doi:10.3390/antibiotics12020234
   Google Scholar
• Scheuerman O, Schechner V, Carmeli Y, et al. Comparison of predictors and mortality between bloodstream infections caused by ESBL-Producing Escherichia coli and ESBL-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2018;39(6):660–667. doi:10.1017/ice.2018.63
   PubMed Web of Science ®Google Scholar
• Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2008;62(1):5–34. doi:10.1093/jac/dkn162
   PubMed Web of Science ®Google Scholar
• Masterton R, Craven D, Rello J, et al. Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development. J Antimicrob Chemother. 2007;60(2):206–213. doi:10.1093/jac/dkm176
   PubMed Web of Science ®Google Scholar
• Song P, Wei Y, Yu X, et al. The comparison analysis of bloodstream infection caused by Klebsiella pneumoniae versus Escherichia coli: incidence, clinical distribution and drug resistance. Minerva Med. 2022;113(5):879–881. doi:10.23736/S0026-4806.22.08010-7
   PubMed Web of Science ®Google Scholar
• Kang CI, Kim SH, Park WB, et al. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother. 2004;48(12):4574–4581. doi:10.1128/AAC.48.12.4574-4581.2004
   PubMed Web of Science ®Google Scholar
• Sung HS, Lee JW, Bae S, et al. Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia. Korean J Intern Med. 2021;36(2):433–440. doi:10.3904/kjim.2019.272
   PubMed Web of Science ®Google Scholar
• Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61–e111. doi:10.1093/cid/ciw353
   PubMed Web of Science ®Google Scholar
• Aliberti S, Dela Cruz CS, Amati F, et al. Community-acquired pneumonia. Lancet. 2021;398(10303):906–919. doi:10.1016/S0140-6736(21)00630-9
   PubMed Web of Science ®Google Scholar
• Goepfert RP, Hutcheson KA, Lewin JS, et al. Complications, hospital length of stay, and readmission after total laryngectomy. Cancer. 2017;123(10):1760–1767. doi:10.1002/cncr.30483
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med. 2004;140(1):26–32. doi:10.7326/0003-4819-140-1-200401060-00008
   PubMed Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710. doi:10.1007/BF01709751
   PubMed Web of Science ®Google Scholar
• Lee J, Hwang JS, Hwang IS, et al. Coprisin-induced antifungal effects in Candida albicans correlate with apoptotic mechanisms. Free Radic Biol Med. 2012;52(11–12):2302–2311. doi:10.1016/j.freeradbiomed.2012.03.012
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 26th informational supplement. CLSI Document M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 27th informational supplement. CLSI Document M100-S27. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 28th informational supplement. CLSI Document M100-S28. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 29th informational supplement. CLSI Document M100-S29. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
   Google Scholar
• Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115(1):92–106. doi:10.1093/oxfordjournals.aje.a113284
   PubMed Web of Science ®Google Scholar
• Chen IR, Lin SN, Wu XN, et al. Clinical and microbiological characteristics of bacteremic pneumonia caused by Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022;12:903682. doi:10.3389/fcimb.2022.903682
   PubMed Web of Science ®Google Scholar
• Ingersoll MA. Sex differences shape the response to infectious diseases. PLoS Pathog. 2017;13(12):e1006688. doi:10.1371/journal.ppat.1006688
   PubMed Web of Science ®Google Scholar
• Silveyra P, Fuentes N, Rodriguez Bauza DE. Sex and gender differences in lung disease. Adv Exp Med Biol. 2021;1304:227–258. doi:10.1007/978-3-030-68748-9_14
   PubMed Web of Science ®Google Scholar
• Gill CM, Nicolau DP; Group E-PGS. Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients. Antimicrob Resist Infect Control. 2022;11(1):146. doi:10.1186/s13756-022-01187-8
   PubMed Web of Science ®Google Scholar
• Lakbar I, Medam S, Ronfle R, et al. Association between mortality and highly antimicrobial-resistant bacteria in intensive care unit-acquired pneumonia. Sci Rep. 2021;11(1):16497. doi:10.1038/s41598-021-95852-4
   PubMed Web of Science ®Google Scholar
• Wang C, Yuan Z, Huang W, et al. Epidemiologic analysis and control strategy of Klebsiella pneumoniae infection in intensive care units in a teaching hospital of People’s Republic of China. Infect Drug Resist. 2019;12:391–398. doi:10.2147/IDR.S189154
   PubMed Web of Science ®Google Scholar
• Zeng M, Xia J, Zong Z, et al. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect. 2023. doi:10.1016/j.jmii.2023.01.017
   PubMedGoogle Scholar
• Bengoechea JA, Sa Pessoa J. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS Microbiol Rev. 2019;43(2):123–144. doi:10.1093/femsre/fuy043
   PubMed Web of Science ®Google Scholar
• Kuo TH, Yang CY, Lee CH, et al. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia. Medicine. 2017;96(26):e7075. doi:10.1097/MD.0000000000007075
   PubMed Web of Science ®Google Scholar
• Chen SC, Wu WY, Yeh CH, et al. Comparison of Escherichia coli and Klebsiella pneumoniae liver abscesses. Am J Med Sci. 2007;334(2):97–105. doi:10.1097/MAJ.0b013e31812f59c7
   PubMed Web of Science ®Google Scholar
• Chan KS, Shelat VG. Klebsiella pneumoniae bacteremia is associated with higher mortality in acute calculous cholangitis as compared to Escherichia coli bacteremia. World J Surg. 2022;46(7):1678–1685. doi:10.1007/s00268-022-06559-0
   PubMed Web of Science ®Google Scholar
• Shelat VG, Chia CL, Yeo CS, et al. Pyogenic liver abscess: does Escherichia coli cause more adverse outcomes than Klebsiella pneumoniae? World J Surg. 2015;39(10):2535–2542. doi:10.1007/s00268-015-3126-1
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Ranjbar R, Behzadi P, et al. Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae. Expert Rev Anti Infect Ther. 2022;20(3):463–472. doi:10.1080/14787210.2022.1990040
   PubMed Web of Science ®Google Scholar
• Chi X, Meng X, Xiong L, et al. Small wards in the ICU: a favorable measure for controlling the transmission of carbapenem-resistant Klebsiella pneumoniae. Intensive Care Med. 2022;48(11):1573–1581. doi:10.1007/s00134-022-06881-0
   PubMed Web of Science ®Google Scholar
• Luterbach CL, Chen L, Komarow L, et al. Transmission of carbapenem-resistant Klebsiella pneumoniae in US hospitals. Clin Infect Dis. 2023;76(2):229–237. doi:10.1093/cid/ciac791
   PubMed Web of Science ®Google Scholar
• Liu C, Dong N, Chan EWC, et al. Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in China, 2016–20. Lancet Infect Dis. 2022;22(2):167–168. doi:10.1016/S1473-3099(22)00009-3
   PubMed Web of Science ®Google Scholar
• Pang F, Jia XQ, Zhao QG, et al. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob. 2018;17(1):13. doi:10.1186/s12941-018-0267-8
   PubMed Web of Science ®Google Scholar
• Hu FP, Guo Y, Zhu DM, et al. CHINET surveillance of bacterial resistance across tertiary hospitals in 2019. Chinese J Infect Chemother. 2020;20(3):233–243. doi:10.16718/j.1009-7708.2020.03.001
   Google Scholar
• Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322–2328. doi:10.1128/AAC.02166-13
   PubMed Web of Science ®Google Scholar
• Kim D, Park BY, Choi MH, et al. Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection. J Antimicrob Chemother. 2019;74(1):190–199. doi:10.1093/jac/dky397
   PubMed Web of Science ®Google Scholar
• Brescini L, Morroni G, Valeriani C, et al. Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy. BMC Infect Dis. 2019;19(1):611. doi:10.1186/s12879-019-4268-9
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943–950. doi:10.1093/cid/cis588
   PubMed Web of Science ®Google Scholar
• Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798–803. 10.1111/j.1469–0691.2011.03514.x.
   PubMed Web of Science ®Google Scholar
• Loncaric I, Beiglbock C, Fessler AT, et al. Characterization of ESBL- and ampc-producing and fluoroquinolone-resistant Enterobacteriaceae isolated from mouflons (Ovis orientalis musimon) in Austria and Germany. PLoS One. 2016;11(5):e0155786. doi:10.1371/journal.pone.0155786
   PubMed Web of Science ®Google Scholar
• John TM, Deshpande A, Brizendine K, et al. Epidemiology and outcomes of community-acquired Escherichia coli pneumonia. Open Forum Infect Dis. 2022;9(1):ofab597. doi:10.1093/ofid/ofab597
   PubMed Web of Science ®Google Scholar
• Luo H, Xiao Y, Hang Y, et al. Comparison of therapy with beta-lactam/beta-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2021;20(1):63. doi:10.1186/s12941-021-00471-6
   PubMed Web of Science ®Google Scholar
• Kim YC, Choi H, Kim YA, et al. Risk factors and microbiological features of recurrent Escherichia coli bloodstream infections. PLoS One. 2023;18(1):e0280196. doi:10.1371/journal.pone.0280196
   PubMed Web of Science ®Google Scholar